NCT03279211

Brief Summary

The main goal of the study is to determine true ileal amino acid digestibility of whey protein isolate (WPI) and zein proteins in healthy subjects equipped with naso-ileal tube. The endogenous losses of proteins and amino acids will be determined by collecting digesta samples after a protein-free diet in a third group of subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 12, 2017

Completed
19 days until next milestone

Study Start

First participant enrolled

October 1, 2017

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2019

Completed
Last Updated

June 3, 2022

Status Verified

May 1, 2022

Enrollment Period

2.2 years

First QC Date

July 18, 2017

Last Update Submit

May 31, 2022

Conditions

Keywords

digestibilitywhey proteinzeinbioavailability

Outcome Measures

Primary Outcomes (1)

  • Determination of the concentration of amino acids from dietary sources (whey or zein) in the ileal digesta collected during 9 hours after meal intake to calculate the digestibility of amino acids from whey or zein protein sources.

    The quantity of amino acids will be determined by HPLC in the ileal digesta collected thanks to the naso-ileal tube during 9 hours after the meal intake. The obligatory endogenous amino acid losses will be estimated by determination of the amino acid content of ileal digesta after intake of the protein-free meal and this value will be subtracted to the values obtained after intake of protein meal to evaluate the quantity of amino acid which comes from dietary sources. Recovery of the indigestible markers (13C-inulin and celite) will allow correction for incomplete collection of digesta.

    Hour 0 to 9 after intake

Secondary Outcomes (3)

  • Determination of the metabolic hormones plasma profile after zein or whey protein intake

    Hour 0 to 9 after intake

  • Determination of the effect of zein and whey protein on glucose homeostasis

    From the evening before the administration to 9 h after the meal.

  • Determination of the effect of zein and whey protein on amino acid plasma concentration

    From the evening before the administration to 9 h after the meal.

Study Arms (3)

Zein protein

EXPERIMENTAL

Zein protein included in the test-meal, 30 g of zein in 500 ml (water + flavour/sugar)

Other: Zein Sigma-Aldrich W555025

Whey protein isolate

EXPERIMENTAL

Whey protein isolate included in the test-meal, 30 g of zein in 500 ml (water + flavour/sugar)

Other: Whey Protein Isolate 894 Fonterra

Protein-free

OTHER

No protein added in the test-meal, only 500 ml of water + flavour/sugar In order to determine the endogenous loss of amino acid in the digesta samples.

Other: Protein-free test-meal

Interventions

30 g of protein powder diluted in water

Whey protein isolate

30 g of protein powder diluted in water

Zein protein

No protein included in the drink made of water and flavour/sugar

Protein-free

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Normal body weight (18 \< BMI \< 30 kg.m-2)
  • Women or men
  • Healthy
  • Insured under the French social security system
  • Signed informed consent
  • For women: use of birth control

You may not qualify if:

  • People under trusteeship
  • Latex, cow milk or corn allergy A
  • HIV, hepatite C virus antibodies, hepatite B virus surface antigen and core antibodies positive
  • Pregnant women
  • Excessive alcohol drinking or drugs intake
  • Hypertension, diabetes, digestive tract, liver or renal diseases, severe heart disease
  • High sport practicing (\> 7h/week)
  • Blood donation in the 3 months prior to the study
  • Participation in a clinical study in the 3 months prior to the study
  • No signed informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CRNH Ile de France

Bobigny, 93900, France

Location

Related Publications (1)

  • Calvez J, Benoit S, Piedcoq J, Khodorova N, Azzout-Marniche D, Tome D, Benamouzig R, Airinei G, Gaudichon C. Very low ileal nitrogen and amino acid digestibility of zein compared to whey protein isolate in healthy volunteers. Am J Clin Nutr. 2021 Jan 4;113(1):70-82. doi: 10.1093/ajcn/nqaa274.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: 3 groups, one for each protein sources (zein and whey) and one for determination of endogenous amino acid losses (protein-free meal)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Clinical Head of Gastroenterology

Study Record Dates

First Submitted

July 18, 2017

First Posted

September 12, 2017

Study Start

October 1, 2017

Primary Completion

December 20, 2019

Study Completion

December 20, 2019

Last Updated

June 3, 2022

Record last verified: 2022-05

Locations